» Articles » PMID: 32774058

Two-day Enema Antibiotic Therapy for Parasite Eradication and Resolution of Symptoms

Overview
Specialty Gastroenterology
Date 2020 Aug 11
PMID 32774058
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: () and () are two protozoan parasites of human bowel that are found throughout the world. There is still debate about the pathogenicity of these protozoans, despite them being commonly associated with gastrointestinal symptoms and can cause health issue in both children and adults. These parasites are usually transmitted through faecal-oral contact particularly under poor hygiene conditions or food/water contamination. Once a person is infected, the parasites live in the large intestine and are passed in the faeces.

Aim: To investigate the effect of triple antibiotic therapy using enema infusion in the treatment of and infections.

Methods: This retrospective longitudinal study was conducted in a single medical centre, which included fifty-four patients (≥ 18 years) who were positive for , or both between 2017 and 2018. The treatment consisted of triple antibiotics that were infused over two consecutive days through rectal enema. Faecal samples were collected from participants pre- and post-treatment and were tested for parasites using microscopy and polymerase chain reaction. Patients' symptoms were recorded prior and after the treatment as well as patient demographic data.

Results: Patients ( = 54), were either positive for (37%), (35%) or both (28%). All patients completed the two-day treatment and no serious adverse effect was reported. The most common side effect experienced by the patients during the treatment was urine discolouration which was cleared by six weeks of follow-up. Common symptoms reported prior to treatment were diarrhoea, abdominal pain, constipation and fatigue. Other symptoms included abdominal discomfort, dizziness and blood in the stool. Eighty-nine percent of patients completed a final stool test post-treatment. At six weeks post-treatment, 79% of patients cleared the parasites from their faeces. Symptoms such as abdominal discomfort, dizziness and blood in the stool decreased significantly at both seven days and six weeks post-treatment ( < 0.040). The enema retention time, bowel preparation, previous antibiotic treatment or previous gastrointestinal problems had no significant effect on parasite eradication.

Conclusion: Overall, eradication of parasites and improvement of clinical outcomes were observed in treated patients, showing the efficacy of this combination to eradicate the parasites and provide positive clinical outcome.

Citing Articles

No evidence of pathogenicity of Dientamoeba fragilis following detection in stools: A case-control study.

Tchamwa Bamini G, Charpentier E, Guemas E, Chauvin P, Fillaux J, Valentin A Parasite. 2024; 31:40.

PMID: 39052010 PMC: 11271704. DOI: 10.1051/parasite/2024041.


Alterations of mouse gut microbiome in alveolar echinococcosis.

Cui Z, Du F, Yu W, Wang Z, Kong F, Xie Z Heliyon. 2024; 10(12):e32860.

PMID: 38988523 PMC: 11234002. DOI: 10.1016/j.heliyon.2024.e32860.


A longitudinal study of Blastocystis in dairy calves from birth through 24 months demonstrates dynamic shifts in infection rates and subtype prevalence and diversity by age.

Santin M, Molokin A, Maloney J Parasit Vectors. 2023; 16(1):177.

PMID: 37264466 PMC: 10236725. DOI: 10.1186/s13071-023-05795-0.

References
1.
Nagata N, Marriott D, Harkness J, Ellis J, Stark D . Current treatment options for Dientamoeba fragilis infections. Int J Parasitol Drugs Drug Resist. 2014; 2:204-15. PMC: 3862407. DOI: 10.1016/j.ijpddr.2012.08.002. View

2.
Hui W, Li T, Liu W, Zhou C, Gao F . Fecal microbiota transplantation for treatment of recurrent C. difficile infection: An updated randomized controlled trial meta-analysis. PLoS One. 2019; 14(1):e0210016. PMC: 6343888. DOI: 10.1371/journal.pone.0210016. View

3.
Kurt O, Dogruman Al F, Tanyuksel M . Eradication of Blastocystis in humans: Really necessary for all?. Parasitol Int. 2016; 65(6 Pt B):797-801. DOI: 10.1016/j.parint.2016.01.010. View

4.
Stensvold C, Smith H, Nagel R, Olsen K, Traub R . Eradication of Blastocystis carriage with antimicrobials: reality or delusion?. J Clin Gastroenterol. 2009; 44(2):85-90. DOI: 10.1097/MCG.0b013e3181bb86ba. View

5.
Nagel R, Bielefeldt-Ohmann H, Traub R . Clinical pilot study: efficacy of triple antibiotic therapy in Blastocystis positive irritable bowel syndrome patients. Gut Pathog. 2014; 6:34. PMC: 4209510. DOI: 10.1186/s13099-014-0034-0. View